3
Announcements
Trials
Browse
Landscape
Sponsor
Cancer Type
Other hematologic neoplasm
6
Gastrointestinal
6
Breast
6
Plasma cell
5
Lymphoid
4
Head & Neck
4
Dermatologic
4
CNS
4
Thoracic
3
Sarcoma
3
Myeloid
3
Gynecologic
3
Other
2
Genitourinary
2
Tumor-Agnostic
1
Other solid neoplasm
1
Other neoplasm
1
Classical hematology
1
Interventions
Everolimus
25
Magnetic Resonance Spectroscopy
13
pembrolizumab
12
pasireotide
12
Sunitinib
11
Octreotide
11
lanreotide
10
cabozantinib
10
lenvatinib
8
Sorafenib
8
Cisplatin
8
Temozolomide
7
Etoposide
7
Bevacizumab
7
pazopanib
6
Paclitaxel
6
Nivolumab
6
Doxorubicin
6
Carboplatin
6
Capecitabine
6
vandetanib
5
gallium Ga 68 dotatate
5
Specimen Handling
5
trametinib
4
lutetium Lu 177 dotatate
4
dabrafenib
4
Mitotane
4
Iodine-131
4
telotristat ethyl
3
surufatinib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Therapeutics
×
Endocrine
×
Clear all
No trials found.